Almirall's Actikerall set for first approvals
This article was originally published in Scrip
Executive Summary
Almirall is set to receive its first approvals for Actikerall (5mg/g fluorouracil and 100mg/g salicylic acid) a topical solution for the treatment of actinic keratosis. It has been granted a positive recommendation by regulatory authorities in Germany, the UK, Austria, Luxembourg, Poland, Czech Republic and Slovakia, for the treatment of palpable and/or moderately thick hyperkeratotic actinic keratosis (grade 1/11) in adults.